CYDECTIN TRICLAMOX 1MG/ML + 50MG/ML ORAL SOLUTION
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
13-05-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
MOXIDECTIN TRICLABENDAZOLE
Available from:
Pfizer Healthcare Ireland
ATC code:
QP54AB52
Therapeutic group:
Endectoparasiticides
Therapeutic area:
Ovine
Authorization date:
2010-10-22
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Cydectin TriclaMox 1mg/ml + 50 mg/ml Oral Solution for sheep
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Oral solution
A clear yellow to brown liquid
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Sheep
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
FOR THE TREATMENT OF MIXED NEMATODE AND FLUKE INFECTIONS IN SHEEP, CAUSED BY MOXIDECTIN AND TRICLABENDAZOLE
SENSITIVE STRAINS OF:
Each ml contains:
ACTIVE SUBSTANCES
Moxidectin
1.0
mg
Triclabendazole
50.0
mg
EXCIPIENTS
Benzyl Alcohol
40.0
mg
Butylhyroxytoluene
1.0
mg
For a full list of excipients see section 6.1
Parasite
ADULT STAGE
L4
INHIBITED STAGES
GASTRO-INTESTINAL NEMATODES:
_Haemonchus contortus_
_Teladorsagia circumcincta_
_Ostertagia trifurcata_
_Trichostrongylus axei_
_Trichostrongylus colubriformis_
_Trichostrongylus vitrinus_
_Nematodirus battus_
_Nematodirus spathiger_
_Nematodirus filicolis_
_Strongyloides papillosus_
_Cooperia curticei_
_Cooperia oncophora_
_Oesophagostomum columbianum_
_Oesophagostomum venulosum_
_Chabertia ovina_
_Trichuris ovis_
RESPIRATORY TRACT NEMATODE:
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 01/12/2011_
_CRN 7011267_
_page number: 1_
The product has a persistent efficacy and protects sheep against infection or re-infection with the following parasites for the period
indicated:
Clinical trials, after experimental and natural infection, have shown that the product is effective against certain benzimidazole
resistant strains of:
._Haemonchus contortus_
._Teladorsagia circumcincta_
._Trichostrongylus colubriformis_
._Cooperia curticei_
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance(s) or to any of the excipient(s).
4.4 SPECIAL WARNI
Read the complete document
